Thyroid gland disorders have become a significant global health concern, with millions of people affected by conditions such as hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer. As awareness grows and diagnostic technologies advance, the global market for thyroid disorder diagnostics and treatment continues to expand. This blog explores the evolving landscape of the thyroid gland disorders market, highlighting key trends, technologies, and growth drivers shaping its future.
The thyroid gland plays a critical role in regulating metabolism, energy generation, and hormone balance. Common thyroid disorders include:
Factors such as iodine deficiency, autoimmune diseases (e.g., Hashimoto’s thyroiditis or Graves’ disease), and radiation exposure can contribute to these conditions.
The global thyroid gland disorders diagnostics and treatment market is witnessing substantial growth, driven by increasing disease prevalence, growing public awareness, and continuous advancements in medical diagnostics. The global market for diagnostics and treatment of thyroid gland disorders was valued at $15.5 billion in 2024 and is estimated to increase from $16.3 billion in 2025 to reach $21.0 billion by 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.